Athenex Stock Price - ATNX

0.01 (0.08%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Athenex Inc ATNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.04 -7.43% 12.95 12.70 13.62 13.54 13.99 20:00:00
Bid Price Ask Price Spread Spread % News
12.50 13.85 1.35 9.75% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,999 822,590 $ 13.06 $ 10,746,057 445,015 8.82 - 22.00
Last Trade Time Type Quantity Stock Price Currency
19:54:01 3 $ 12.96 USD

Athenex Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.00B 77.38M $ -117.44M -1.80 - 70.09M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Athenex News

Loading Messages....

Latest ATNX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATNX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week14.6815.1512.7014.61585,843-1.73-11.78%
1 Month14.0315.6712.7014.46439,266-1.08-7.7%
3 Months15.5822.0012.7014.97848,777-2.63-16.88%
6 Months15.0122.008.8213.70878,698-2.06-13.72%
1 Year13.3022.008.8214.33708,320-0.35-2.63%
3 Years12.0022.008.8214.90440,0560.957.92%
5 Years12.0022.008.8214.90440,0560.957.92%

Athenex Description

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company's mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. The company has organized its business model into three segments, Oncology Innovation Platform, Commercial Platform and Global Supply Chain Platform with operations in both the U.S. and China.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.